Academy’s Monthly Bulletin: Jan 2024

Academy's Monthly Bulletin: Jan 2024

A Monthly Newsletter Dedicated to Our Academy Membership Community!

Academy's Update for Jan 2024:

Happy New Year to all our students 🙂

Here is the summary of our upcoming lecture schedule & updates for Jan 2024:

[Jan 13]:
Drug Interactions: Antidepressants and Caffeine

Caffeine is a natural stimulant that affects the central nervous system leading to increased alertness and reduced fatigue. Many people rely on caffeine to kick-start their day or to power through demanding tasks, and it’s readily available in various forms, from coffee and tea to energy drinks and supplements.

Antidepressants, which are aimed to alleviate symptoms of depression, are needed daily to reach the therapeutic levels. As a result, the combination of these two substances can potentially lead to interactions that need careful consideration. 

Understanding the potential interactions and taking proactive steps to manage them can contribute to a healthier and more balanced approach.

This will be our new chapter addition to the academy’s Psychotropics Drug-Drug Interaction lecture series, where Dr. Singh will summarize this clinically relevant topic.

[Jan 17]: Adding Oral Contraceptives to Lamotrigine: How to Manage?

The interaction between oral contraceptives and lamotrigine is a topic of clinical significance, as they both influence the metabolism of each other. Healthcare professionals must carefully monitor and adjust medication doses to ensure optimal therapeutic outcomes while minimizing potential adverse effects. 

This video will be posted on our YouTube Channel. 

[Jan 20]: New Era of Weight Loss Medications: Basics & Beyond

Antipsychotic medications are known for their potential to induce weight gain. This side effect can have significant implications for individuals’ physical health, mental well-being, and treatment adherence.

In recent years, a groundbreaking shift has occurred in the realm of weight loss, ushering in a new era marked by the emergence of innovative medications. Despite the well-established benefits of a healthy diet and regular physical activity, many individuals struggle to achieve and maintain a sustainable weight. This has prompted a demand for novel approaches to weight loss that can address the diverse needs of individuals facing this health issue.

The emergence of new weight loss medications represents a promising development in the field of obesity management. Dr. Kaur (Family Medicine) has summarized this topic in the academy’s next chapter in the Adverse Events: Antipsychotics section.

[Jan 24]: Can Imipramine help with Generalized Anxiety Disorder?

For individuals facing treatment-resistant Generalized Anxiety Disorder (GAD), exploring alternative medication options becomes crucial in the quest for relief. When traditional treatments such as selective serotonin reuptake inhibitors (SSRIs) or benzodiazepines prove ineffective, healthcare professionals should consider other classes of medications.

[Jan 27]: Should you consider Lamotrigine for Binge Eating Disorder?

Treatment-resistant binge eating disorder (BED) presents a challenging and complex clinical scenario, characterized by recurrent episodes of consuming large quantities of food, often rapidly and to the point of discomfort, accompanied by a sense of loss of control. 

Despite the availability of various therapeutic interventions, some individuals with BED exhibit resistance to traditional treatments. The conventional approaches to BED typically involve psychotherapy, such as CBT, interpersonal therapy, and dialectical behavior therapy. Additionally, pharmacological options, such as SSRIs have been explored. However, when individuals do not respond adequately to these interventions, the disorder is considered treatment-resistant.

Lamotrigine can be one of the options for treatment-resistant BED. Watch our YouTube video describing the role of lamotrigine in BED.

INTERESTED IN ACCESS TO THIS & OTHER CLINICALLY RELEVANT LECTURE SERIES?

JOIN ACADEMY MEMBERSHIP:

This is a closed membership for medical professionals only.

  • 400+ Clinically Relevant Chapters: Each chapter within these sections is of direct clinical relevance for your daily practice. 
  • Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
  • Clinical Case Discussion: Dr. Singh (Psychiatry) and Dr. Kaur (Family Medicine) discuss clinical cases to integrate the clinical cases from Psychiatry and Medicine.
  • Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
  • Goal: is to have all important clinically relevant topics in one place for ease of access.
GENERAL
$ 99/YR
  •  
STUDENTS
$ 75/YR
  •  

DISCOUNTS AVAILABLE FOR: Residents & Students ONLY.

Email us your student information (program information and way to confirm your student status) to: HSingh@PsychiatryEducationForum.com

© 2024 All Rights Reserved.

Join Email Newsletter

* indicates required

Related Articles